Faith-Based Investor Group Calls for Transparency in Drug Pricing

A group of 300 institutional investors, including many with ties to religious organizations, is waging a new campaign to press drugmakers to justify their price increases.

Source: WSJ.com: Health - October 25, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news